Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area

Published:2015-06 Issue:12 Volume:112 Page:1911-1920
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Sideras K,Bots S J,Biermann K,Sprengers D,Polak W G,IJzermans J N M,de Man R A,Pan Q,Sleijfer S,Bruno M J,Kwekkeboom J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201592.pdf

Reference81 articles.

1. Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, Leung T, Gansukh B, Saltz LB (2010) Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial. JAMA 304: 2154–2160.

2. Brennan DJ, Rexhepaj E, O'Brien SL, McSherry E, O'Connor DP, Fagan A, Culhane AC, Higgins DG, Jirstrom K, Millikan RC, Landberg G, Duffy MJ, Hewitt SM, Gallagher WM (2008) Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer. Clin Cancer Res 14: 2681–2689.

3. Brumm C, Schulze C, Charels K, Morohoshi T, Kloppel G (1989) The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours. Histopathology 14: 503–513.

4. Cao Y, Karsten U, Otto G, Bannasch P (1999) Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch 434: 503–509.

5. Chau GY, Lee AF, Tsay SH, Ke YR, Kao HL, Wong FH, Tsou AP, Chau YP (2007) Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma. Histopathology 51: 204–218.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for hepatocellular carcinoma;JHEP Reports;2024-10

2. An Immunohistochemical Study of MAGE Proteins in Hepatocellular Carcinoma;Diagnostics;2024-08-05

3. Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future;Journal of Clinical and Translational Hepatology;2024-02-28

4. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake;Frontiers in Immunology;2024-02-19

5. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma;Frontiers in Immunology;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3